Similarly, our results are similar to those in gastric cancer reporting that gastric cancer migration due to HER3/HER4 transactivation, caused by histone deacetylase inhibitors, was mediated by MAPK activation, but not PI3K/Akt activation [117]. The gene discussed is ERBB3; the disease is gastric cancer.